Henry Schein | HSIC - Assets


Henry Schein reported $11.3B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Agilent USD 13.07B 252M Mar/2026
Align Technology USD 6.31B 80.48M Mar/2026
Bruker USD 6.13B 110.7M Mar/2026
Cardinal Health USD 56.69B 1.39B Mar/2026
Charles River Laboratories USD 7.73B 594.89M Mar/2026
Cigna USD 153.27B 4.65B Mar/2026
Concord Medical Services Hldg CNY 6.73B 663.4M Jun/2025
Cooper Companies USD 12.48B 58.1M Mar/2026
CVS Health USD 252.97B 564M Mar/2026
Danaher USD 83.54B 80M Mar/2026
Dentsply International USD 5.23B 200M Mar/2026
Encompass Health USD 7.31B 223.5M Mar/2026
Henry Schein USD 11.3B 89M Mar/2026
Idexx Laboratories USD 3.39B 34.74M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
Laboratory Of America USD 19.09B 694.4M Mar/2026
McKesson USD 82.32B 1.87B Mar/2026
Mettler Toledo International USD 3.67B 43.73M Mar/2026
Owens Minor USD 2.42B 35.78M Mar/2026
Quest Diagnostics USD 16.67B 448M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Stryker USD 46.29B 1.55B Mar/2026
Tenet Healthcare USD 31.2B 1.53B Mar/2026
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Universal Health Services USD 15.68B 153.55M Mar/2026
Veradigm USD 1.5B 185.94M Dec/2022
Waters USD 24.53B 19.45B Mar/2026
Zimmer Biomet Holdings USD 22.72B 370.1M Mar/2026
Zoetis USD 15.15B 313M Mar/2026